Live from the NIH registry
Studies recruiting near Syracuse right now
Top 25 of 260 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Crouse Health System and Crouse Medical Practice — Syracuse, New York (0.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
SUNY Upstate Medical Center — Syracuse, New York (0.5 mi)
· Sponsor: GT Medical Technologies, Inc.
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
Spasticity, Movement Disorders
N/A
Interventional 10 participants sought
Syracuse VA Medical Center, Syracuse, NY — Syracuse, New York (0.5 mi)
· Sponsor: VA Office of Research and Development
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Lupus Research Alliance
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Phase 3
Interventional 600 participants sought
Investigative Site US082 — East Syracuse, New York (3.7 mi)
· Sponsor: Incyte Corporation
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
Hematology-Oncology Associates of CNY — East Syracuse, New York (3.7 mi)
· Sponsor: Janssen Research & Development, LLC
Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief
Neck Pain Musculoskeletal, Neck Pain Treatment
N/A
Interventional 160 participants sought
PROActivePT — Syracuse, New York (0.5 mi)
· Sponsor: Baylor University
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
Venous Thromboembolism, Head and Neck Cancer
Phase 4
Interventional 76 participants sought
SUNY Upstate — Syracuse, New York (0.5 mi)
· Sponsor: Kiranya Arnold
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: NRG Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Central New York Clinical Research — Manlius, New York (8.8 mi)
· Sponsor: TriGemX Bio, Inc.
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: SWOG Cancer Research Network
PEG3350 vs Senna After Urogyn Surgery
Obstructive Defecation Syndrome, Postoperative Constipation
Phase 4
Interventional 254 participants sought
St. Joseph's Health Hospital — Syracuse, New York (0.5 mi)
· Sponsor: St. Joseph's Health, New York
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Phase 2
Interventional 150 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi)
· Sponsor: Novartis Pharmaceuticals
Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress
Psychological Distress
N/A
Interventional 384 participants sought
Syracuse VA Medical Center, Syracuse, NY — Syracuse, New York (0.5 mi)
· Sponsor: VA Office of Research and Development
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Phase 3
Interventional 450 participants sought
Associated Med Professionals of NY — Syracuse, New York (0.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
Hematology Oncology Associates of Central New York — Camillus, New York (8.1 mi)
· Sponsor: Jazz Pharmaceuticals
A Study of Methylprednisolone in People Having Liver Surgery
Hepatectomy
Phase 3
Interventional 750 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
State University of New York Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
AI-Assisted Treatment for Residual Speech Sound Disorders
Speech Sound Disorder
N/A
Interventional 26 participants sought
Syracuse University — Syracuse, New York (0.5 mi)
· Sponsor: Syracuse University
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Syracuse VA Medical Center — Syracuse, New York (0.5 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
Phase 3
Interventional 480 participants sought
SUNY Upstate Medical University — Syracuse, New York (0.5 mi)
· Sponsor: BioNTech SE
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Neoplasms, Healthy
Phase 1
Interventional 41 participants sought
Ichor Research — Syracuse, New York (0.5 mi)
· Sponsor: Eli Lilly and Company